MedTechnology
ByChina’s $2-3B AI Healthcare Pilots Launch: Rural Revolution or Data Control Play?
China’s National Health Commission launched pilots March 1-3, 2026, under its CNY 15-20B ($2-3B) AI strategy—rolling out AI…
Azitra Spotlights ATR-12 Phase 1b Data at BIO Summit Miami—50% Enrollment Safety Win Signals Microbiome Biotech Fundraising Surge
Published by BioNextAI Media – Azitra, Inc. (NYSE American: AZTR) takes center stage at the BIO Investment & Growth…
Is Johnson & Johnson Preparing to Divest DePuy Synthes in a $20 Billion Strategic Pivot Toward Pharmaceuticals?
Will Johnson & Johnson’s Orthopedics Review Reshape the Global MedTech Landscape? Johnson & Johnson is reportedly exploring a…
Can Foundation Medicine and Manifold Redefine Precision Oncology Through AI-Driven Genomic Analytics?
Are Foundation Medicine and Manifold Signaling the Next Evolution of AI-Integrated Oncology Intelligence? In a strategic move to…
Can Novo Nordisk’s Newly EU-Approved Wegovy Pill Make Weight Loss Treatment as Simple as Taking a Daily Tablet for Millions Across Europe?
Key Highlights A Landmark Shift From Injection to Tablet The European Commission’s authorization marks the first time a…
Is Eli Lilly’s Reported $2 Billion Pursuit of AtaiBeckley About to Redefine the Future of Psychedelic Medicine?
Key Highlights A Premium Bet on Psychedelic Innovation Eli Lilly is negotiating a takeover of AtaiBeckley at a…
